The capacity of the ZIKV to cross the CTB barrier seems to be the result of a sum of factors, including greater infection and replication efficiency, better capacity to activate the mTOR machinery, and a limited inflammatory and chemotactic response with low IFN activity. This evidence concerns the gene IFNA1 and infection.